Ligand Pharmaceuticals Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	18.81	2.84	2.14	0.51
Short-Term Investments	0.28	0.11	0.98	0.75
Cash & Short-Term Investments	19.08	2.96	3.12	1.26
Cash Growth	545.23%	-5.34%	147.36%	-
Accounts Receivable	0.61	0.75	0.36	0.08
Other Receivables	0.39	1	0.04	0.34
Receivables	1.01	1.75	0.4	0.42
Inventory	1.49	0.43	0.21	0.12
Prepaid Expenses	0.27	0.14	0.03	0.03
Other Current Assets	0.1	0.32	0.4	0.03
Total Current Assets	21.95	5.6	4.16	1.85
Property, Plant & Equipment	28.94	30.15	10.42	6.19
Long-Term Investments	-	-	-	0.02
Other Intangible Assets	0	0	0.01	0.01
Long-Term Deferred Tax Assets	0.05	0.23	0.24	0.69
Other Long-Term Assets	2.98	3.01	-	-
Total Assets	53.93	38.99	14.82	8.77
Accounts Payable	1.75	0.98	0.33	0.06
Accrued Expenses	2.8	1.62	0.84	0.17
Short-Term Debt	-	2.01	0.09	2.61
Current Portion of Long-Term Debt	3.22	1.38	1.36	1.87
Current Portion of Leases	6.67	5.52	1.74	3.02
Current Income Taxes Payable	1	0.52	0.22	-
Current Unearned Revenue	-	-	-	0.05
Other Current Liabilities	1.97	3.59	1.56	1.39
Total Current Liabilities	17.4	15.62	6.15	9.17
Long-Term Debt	5.71	1.77	0.03	0.44
Long-Term Leases	7.19	12.53	4.9	0.9
Long-Term Deferred Tax Liabilities	0.37	0.02	0.05	-
Other Long-Term Liabilities	0.99	0.9	0.35	0.29
Total Liabilities	31.65	30.84	11.47	10.8
Common Stock	17.01	8.9	5.82	3.39
Retained Earnings	2.47	-1.94	-4.85	-5.99
Comprehensive Income & Other	0.63	0.76	1.25	0.37
Total Common Equity	20.1	7.71	2.22	-2.24
Minority Interest	2.17	0.44	1.12	0.2
Shareholders' Equity	22.27	8.15	3.35	-2.03
Total Liabilities & Equity	53.93	38.99	14.82	8.77
Total Debt	22.78	23.21	8.13	8.84
Net Cash (Debt)	-3.7	-20.25	-5	-7.58
Net Cash Per Share	-0.01	-0.09	-0.03	-0.05
Filing Date Shares Outstanding	400	356.75	156.17	148.66
Total Common Shares Outstanding	400	356.75	156.17	148.66
Working Capital	4.55	-10.02	-1.99	-7.32
Book Value Per Share	0.05	0.02	0.01	-0.02
Tangible Book Value	20.1	7.71	2.22	-2.24
Tangible Book Value Per Share	0.05	0.02	0.01	-0.02
Machinery	8.64	4.96	3	2.28
Construction In Progress	0.15	1.95	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.